Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (121-130 of 1,023) with videos related to

Pageof 103
Sort By:
Current Opinion in Pharmacology|November 21, 2001
Pharmacological management of high triglycerides and low high-density lipoprotein cholesterolP O Szapary, D J Rader
JAMA|August 18, 1993
Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic diseaseD J Rader, H B Brewer
Journal of the American College of Cardiology|February 11, 2017
Intracoronary Imaging, Reverse Cholesterol Transport, and Transcriptomics: Precision Medicine in CAD?Adnan K Chhatriwalla, Daniel J Rader
Cell Metabolism|April 9, 2020
Systematically Sifting Big Data to Identify Novel Causal Genes for Human TraitsNicholas J Hand, Daniel J Rader
The Lancet. Neurology|December 29, 2015
Human genetics shines a light on ischaemic strokeBenjamin F Voight, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|January 10, 2015
Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human geneticsSumeet A Khetarpal, Daniel J Rader
Circulation|February 25, 2020
Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?Michael G Levin, Daniel J Rader
Nature Medicine|September 11, 2012
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?Daniel J Rader, Alan R Tall
Annual Review of Medicine|January 16, 2014
Future of cholesteryl ester transfer protein inhibitorsDaniel J Rader, Emil M deGoma
Nature|September 24, 2024
Yo-yo dieting accelerates cardiovascular disease by reprogramming the immune systemDaniel J Rader, Kate Townsend Creasy
Pageof 103

Showing results (121-130 of 1,023) with videos related to

Sort By:
Pageof 103
Current Opinion in Pharmacology|November 21, 2001
Pharmacological management of high triglycerides and low high-density lipoprotein cholesterolP O Szapary, D J Rader
JAMA|August 18, 1993
Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic diseaseD J Rader, H B Brewer
Journal of the American College of Cardiology|February 11, 2017
Intracoronary Imaging, Reverse Cholesterol Transport, and Transcriptomics: Precision Medicine in CAD?Adnan K Chhatriwalla, Daniel J Rader
Cell Metabolism|April 9, 2020
Systematically Sifting Big Data to Identify Novel Causal Genes for Human TraitsNicholas J Hand, Daniel J Rader
The Lancet. Neurology|December 29, 2015
Human genetics shines a light on ischaemic strokeBenjamin F Voight, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|January 10, 2015
Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human geneticsSumeet A Khetarpal, Daniel J Rader
Circulation|February 25, 2020
Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?Michael G Levin, Daniel J Rader
Nature Medicine|September 11, 2012
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?Daniel J Rader, Alan R Tall
Annual Review of Medicine|January 16, 2014
Future of cholesteryl ester transfer protein inhibitorsDaniel J Rader, Emil M deGoma
Nature|September 24, 2024
Yo-yo dieting accelerates cardiovascular disease by reprogramming the immune systemDaniel J Rader, Kate Townsend Creasy
Pageof 103